Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0039483 (
giant cell arteritis
)
3,204
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The case of a 67 years old woman with
giant cell arteritis
and
neuritis
multiplex is reported. The diagnosis was based on the microscopic appearances of temporal artery biopsy specimens. The authors described the involvement of peripheral nerves in this disease and made differential diagnosis with polyarteritis nodosa. There was also hemorragic infarction of the brain without giant-cells in brain vessels. It is concluded that this diagnosis should be considered in any elderly patient with peripheral neuropathy.
...
PMID:[Multiple neuropaty caused by giant cell arteritis. Clinico-pathological report of a case]. 68 60
Giant cell arteritis
with coronary involvement is an uncommon event, often discovered at autopsy after a myocardial infarction. We report the case of a 70-year-old female with unstable angina pectoris persisting despite angioplasty and antianginal treatment, associated with chronically increased erythrocyte sedimentation rate. Temporal artery biopsy was negative but ophthalmic assessment showed sequelae of ischaemic optical
neuritis
. Response to prednisone therapy was striking, with complete disappearance of angina pectoris, normalization of erythrocyte sedimentation rate and decreased thallium uptake at scintigraphy. This is the first case of
giant cell arteritis
of the coronary arteries seen after attempted therapy with percutaneous transluminal coronary angioplasty. Such findings justify considering
giant cell arteritis
each time a case of coronary manifestations with increased erythrocyte sedimentation rate resists medical treatment, or recurs after coronary angioplasty.
...
PMID:Inflammatory arteritis with reversible coronary localization in a 70-year-old woman. 275 21
Third, fourth and sixth cranial nerve palsy is a less common complication of
giant cell arteritis
than ischemic optic neuritis. Nevertheless, it occurs in at least 10% of cases. A case of
giant cell arteritis
with third nerve palsy which resolved under corticosteroid therapy is reported. The incidence of ocular complications is assessed from a review of the cases previously seen in the department and of data from the medical literature. The authors believe that the index patient has ischemic
neuritis
rather than myositis. It is concluded that
giant cell arteritis
should be considered at an early reversible stage.
...
PMID:[Involvement of oculomotor nerves. A little-known complication of Horton's disease]. 629 74
Mononeuritis multiplex involving median or common peroneal nerves, presumed to be caused by arteritis of the vasa nervorum, is a relatively rare complication of
giant cell arteritis
. We present two cases of popliteal
neuritis
complicating
temporal arteritis
during corticosteroid treatment.
...
PMID:[Neuropathy of the common peroneal nerve caused by giant cell arteritis]. 901 41
Reduction in jaw opening is a neglected symptom of
giant cell arteritis
(
GCA
) in clinical practice and in the scientific literature. We describe the case of a 71-year-old woman with
GCA
who was misdiagnosed as occipital
neuritis
and craniomandibular dysfunction because of headaches in the occipital region and reduction in jaw opening. The reported case reminds us not to overlook reduction in jaw opening as a symptom to reveal
GCA
in elderly patients.
...
PMID:Reduction in jaw opening: a neglected symptom of giant cell arteritis. 2116 30
Ipilimumab is a novel humanized monoclonal antibody directed against cytotoxic T lymphocyte antigen 4, a T-cell surface molecule involved in down-regulation and suppression of the T cell response to stimuli. Patients treated with ipilimumab are at risk for immune-related adverse events involving the skin, digestive tract, liver and endocrine organs. Few case reports of immune-related adverse effects involving central or peripheral nervous system due to ipilimumab are published. These include inflammatory myopathy, aseptic meningitis, severe meningo-radiculo-
neuritis
,
temporal arteritis
, Guillain-Barre syndrome, and posterior reversible encephalopathy syndrome. We report the first case of ipilimumab-induced progressive necrotic myelopathy.
...
PMID:Ipilimumab-induced necrotic myelopathy in a patient with metastatic melanoma: A case report and review of literature. 2571 27